Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogens
Background The rapid increase in antibiotic resistance by various bacterial pathogens underlies the significance of developing new therapies and exploring different drug targets. A fraction of bacterial pathogens abbreviated as ESKAPE by the European Center for Disease Prevention and Control have be...
Main Authors: | Sadia Naz, Tony Ngo, Umar Farooq, Ruben Abagyan |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2017-09-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/3765.pdf |
Similar Items
-
Agenții patogeni ESKAPE și rezistența la antimicrobiene
by: Daiana Ionela Cocos, et al.
Published: (2023-12-01) -
CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies
by: Manuel González de Aledo, et al.
Published: (2021-06-01) -
Antibacterial Activity of Cerium Oxide Nanoparticles against ESKAPE Pathogens
by: Mushtaq A. Dar, et al.
Published: (2022-01-01) -
Essential Metabolic Routes as a Way to ESKAPE From Antibiotic Resistance
by: Angélica Luana C. Barra, et al.
Published: (2020-02-01) -
Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections
by: Yizheng Qian, et al.
Published: (2023-08-01)